As for pSS patients at early stage, xerostomia, ANA, ANA and RF double positive, anti-Ro52, and IHC score of nuclear EpICD were excluded from the regression analysis because they did not show significant difference between non-SS controls and pSS patients at early stage. Here, TRIM21 is linked to xerostomia.